Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. 1977

M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni

The behaviour of bronchial reactivity to PGF2alpha was studied in asthmatic patients under various experimental conditions. Premedication with aminophylline, i.v., and, to a lesser extent, with DSCG afforded a partial protection, while beclomethasone dipropionate was inactive under this point of view. Diftalone, a new non-steroid anti-inflammatory agent, was well tolerated in 9 aspirin-intolerant asthmatic patients, and did not modify the bronchial response to PGF2alpha which was found to be generally lower then that of other aspirin-tolerant asthmatic patients. PGE 1-2 and DSCG prevented the bronchospasm induced by inhalation or ingestion of acetylsalicylic acid in a small group of patients. Good protection was also reached with PGE1-2 in the exercise-induced bronchospasm.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D011465 Prostaglandins, Synthetic Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity. PG Analog,PG Analogs,Prostaglandin Analog,Prostaglandin Analogs,Prostaglandin Analogue,Synthetic Prostaglandin,Prostaglandin Analogues,Synthetic Prostaglandins,Analog, PG,Analog, Prostaglandin,Analogs, PG,Analogs, Prostaglandin,Analogue, Prostaglandin,Analogues, Prostaglandin,Prostaglandin, Synthetic
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females

Related Publications

M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni
January 1980, Advances in prostaglandin and thromboxane research,
M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni
January 1978, Archivum immunologiae et therapiae experimentalis,
M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni
June 1978, British medical journal,
M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni
November 2014, Allergy,
M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni
July 1989, Thorax,
M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni
July 1986, European journal of respiratory diseases,
M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni
April 1984, European journal of respiratory diseases,
M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni
October 1995, European journal of epidemiology,
M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni
May 1997, The European respiratory journal,
M Pasargiklian, and S Bianco, and L Allegra, and N E Moavero, and G Petrigni, and M Robuschi, and A Grugni
January 1997, The Journal of asthma : official journal of the Association for the Care of Asthma,
Copied contents to your clipboard!